Herpes zoster is readily recognized after grouped vesicles appear in a unilateral dermatomal distribution. Before vesiculation, however, erythema, papules, or edematous plaques may resemble eczema, contact dermatitis, or an arthropod reaction. Recent reports of C7 zoster mistaken for dermatitis or scabies, painless occipital zoster mimicking atopic dermatitis, and nonvesicular zoster overlapping with leukocytoclastic vasculitis illustrate that pruritus, absent pain, and eczematous morphology do not safely exclude evolving zoster [1–3].

An important problem is temporal asymmetry between clinical encounters. The first clinician may see only an indistinct unilateral eruption; the later clinician may see vesiculation, dermatomal clustering, pain, dysesthesia, or crusting. Patients may understandably conclude that the later clinician was more skilled and that the initial clinician missed an obvious diagnosis. Yet the decisive information may simply not have existed at the first visit. What changed was often the disease phenotype, not the clinician’s competence. Knowledge of the eventual diagnosis can also produce hindsight bias, making earlier care appear less reasonable than it was with the information then available [4]. This distinction does not excuse missed red flags; it requires the initial encounter to be judged from the contemporaneous evidence.

The appropriate response is neither forced certainty nor dismissal, but diagnostic safety-netting. Clinicians should document the baseline distribution, consider photography, explain that the eruption may evolve, and arrange reassessment within 24-48 hours when suspicion remains. Patients should return promptly for clustered vesicles, increasing pain, burning, numbness, or further unilateral extension. Findings favoring zoster include grouped papules separated by normal skin, an approximately dermatomal pattern, respect for the midline, and sensory symptoms disproportionate to visible inflammation. A confluent poorly demarcated plaque with diffuse scale, excoriation, or oozing favors dermatitis, although substantial overlap remains.

When available, lesion-based varicella-zoster virus polymerase chain reaction testing can support atypical diagnoses [5,6]. Selective empirical antiviral therapy may be reasonable when several risk features converge, particularly older age, immunosuppression, a high-consequence cranial site, prominent dysesthesia, near-dermatomal clustering, or inability to ensure rapid reassessment. Evidence before a characteristic eruption remains limited, so treatment should be individualized and should not retrospectively be used to confirm the diagnosis.

Early herpes zoster is best approached as an evolving probability rather than a binary judgment from one clinical snapshot. A safety-net protects patients from delayed recognition while reducing unfair retrospective blame of the clinician who encountered the disease before its full morphology emerged.

ETHICS STATEMENT

Ethics committee approval and informed consent were not required because this opinion piece reports no original patient-level data or identifiable patient information.

REFERENCES

1.  Nizam MA, Iqbal A, Chaudry S, Ayyazuddin M, Farooq U. A rare case of herpes zoster with C7 involvement mimicking dermatitis:an elusive diagnosis. Discoveries (Craiova). 2025;13:e221.

2.  Inamoto A, Taniguchi T, Fujii Y, Miyoshi S. Varicella-zoster virus meningitis with hypoglycorrhachia, presenting with painless occipital herpes zoster mimicking atopic dermatitis. BMJ Case Rep. 2025;18:e258230.

3.  Cohn H, Hennessy J, Cotell S, Fabbro S. When two truths collide:overlapping herpes zoster and leukocytoclastic vasculitis in an atypical presentation. Diagnosis (Berl). Published online November 10, 2025. doi:10.1515/dx-2025-0134.

4.  Plaum P, Visser LN, de Groot B, Morsink MEB, Duijst WLJM, Candel BGJ. Using case vignettes to study the presence of outcome, hindsight, and implicit bias in acute unplanned medical care:a cross-sectional study. Eur J Emerg Med. 2024;31:260-6.

5.  Fan HR, Zhang EM, Fei Y, Huang B, Yao M. Early diagnosis of herpes zoster neuralgia:a narrative review. Pain Ther. 2023;12:893-901.

6.  Centers for Disease Control and Prevention. Laboratory testing for varicella-zoster virus (VZV). Updated May 10, 2024. Accessed July 17, 2026. https://www.cdc.gov/chickenpox/php/laboratories/index.html.